PortfoliosLab logo

Acorda Therapeutics, Inc. (ACOR)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Acorda Therapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $136 for a total return of roughly -98.64%. All prices are adjusted for splits and dividends.

ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACOR

Acorda Therapeutics, Inc.


Acorda Therapeutics, Inc. had a return of -28.57% year-to-date (YTD) and -69.27% in the last 12 months. Over the past 10 years, Acorda Therapeutics, Inc. had an annualized return of -44.02%, while the S&P 500 had an annualized return of 9.86%, indicating that Acorda Therapeutics, Inc. did not perform as well as the benchmark.

1 month-38.20%-0.66%
6 months66.67%5.67%
1 year-69.27%-10.89%
5 years (annualized)-66.87%8.95%
10 years (annualized)-44.02%9.86%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Acorda Therapeutics, Inc. Sharpe ratio is -0.32. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History

Acorda Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Acorda Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acorda Therapeutics, Inc. is 99.90%, recorded on Sep 29, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.9%Jan 27, 20151934Sep 29, 2022
-66.96%Feb 13, 2006155Sep 22, 20061Sep 25, 2006156
-55.62%Jul 29, 200882Nov 20, 2008325Mar 11, 2010407
-52.87%May 4, 2010359Oct 3, 2011384Apr 16, 2013743
-37.5%May 8, 200789Sep 12, 200794Jan 28, 2008183
-37.06%Jan 29, 200829Mar 10, 200858Jun 2, 200887
-31.06%Apr 22, 2013181Jan 7, 2014246Dec 29, 2014427
-29.77%Feb 21, 200718Mar 16, 200728Apr 26, 200746
-23.59%Nov 24, 200627Jan 4, 200723Feb 7, 200750
-21.36%Sep 27, 20062Sep 28, 20063Oct 3, 20065

Volatility Chart

Current Acorda Therapeutics, Inc. volatility is 60.41%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)